Multiplex Biomarker Imaging Market Size, Share, & Trends Analysis Report by 2032
Multiplex Biomarker Imaging Market by Application (Drug Safety, Oncology Studies, and Genetic Characterization Studies), by Imaging Techniques (Immuno Fluorescence (IF) Assay, Tissue Microarray (TMA) Assay, Immunohistochemistry (IHC) Assay, Fluorescent in the Situ Hybridization (FISH) Assay, and Toponome Imaging System (TIS)), and by End-User (Research Institutes Government & Private, Clinical Labs, and Pharmaceutical & Biotechnology): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 469.57 Million | USD 1,309.50 Million | 12.07% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global multiplex biomarker imaging market, 2024 - 2032 (USD Million)
- 2.2. Global multiplex biomarker imaging market : Snapshot
- Chapter 3. Global Multiplex Biomarker Imaging- Market Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global multiplex biomarker imaging market drivers: Impact analysis
- 3.2.2. Increasing cancer and tumor-related cases
- 3.2.3. Cost effective in nature
- 3.2.4. Provides better results of the analysis which includes thousands of tissue in the single turn
- 3.3. Market Restraints
- 3.3.1. Stringent policies of the government
- 3.3.2. Complex process
- 3.3.3. Ethical issue
- 3.4. Opportunities
- 3.4.1. Technique that has the potential for the anticancer drug discovery
- 3.4.2. Growing healthcare end-user offers huge potential for multiplex biomarker imaging
- 3.5. Porter's five forces analysis
- 3.5.1. Bargaining power of suppliers
- 3.5.2. Bargaining power of buyers
- 3.5.3. Threat from new entrants
- 3.5.4. Threat from new substitutes
- 3.5.5. Degree of competition
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by application
- 3.6.2. Market attractiveness analysis, by imaging techniques
- 3.6.3. Market attractiveness analysis, by end use
- Chapter 4. Global Multiplex Biomarker Imaging Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global multiplex biomarker imaging market: company market share, 2024
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Product Launch
- 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
- 4.2.4. Research and Development, Regional Expansion
- 4.1. Company market share analysis
- Chapter 5. Global Multiplex Biomarker Imaging Market - Application Segment Analysis
- 5.1. Global multiplex biomarker imaging market: application overview
- 5.1.1. Global multiplex biomarker imaging market revenue share, by application, 2018 and 2032
- 5.2. Drug Safety
- 5.2.1. Global multiplex biomarker imaging market for drug safety, 2024 - 2032 (USD Million)
- 5.3. Oncology Studies
- 5.3.1. Global multiplex biomarker imaging market for oncology studies, 2024 - 2032 (USD Million)
- 5.4. Genetic Characterization Studies
- 5.4.1. Global multiplex biomarker imaging market for genetic characterization studies, 2024 - 2032 (USD Million)
- 5.1. Global multiplex biomarker imaging market: application overview
- Chapter 6. Global Multiplex Biomarker Imaging Market - Imaging Techniques Segment Analysis
- 6.1. Global multiplex biomarker imaging market: imaging techniques overview
- 6.1.1. Global multiplex biomarker imaging market revenue share, by imaging techniques, 2018 and 2032
- 6.2. Immuno Fluorescence (IF) Assay
- 6.2.1. Global multiplex biomarker imaging market for immunofluorescence (IF) assay, 2024 - 2032 (USD Million)
- 6.3. Tissue Microarray (TMA) Assay
- 6.3.1. Global multiplex biomarker imaging market for tissue microarray (TMA) assay, 2024 - 2032 (USD Million)
- 6.4. Immunohistochemistry (IHC) Assay
- 6.4.1. Global multiplex biomarker imaging market for immunohistochemistry (IHC) assay, 2024 - 2032 (USD Million)
- 6.5. Fluorescent in the Situ Hybridization (FISH) Assay
- 6.5.1. Global multiplex biomarker imaging market for fluorescent in the situ hybridization (fish) assay, 2024 - 2032 (USD Million)
- 6.6. Toponome Imaging System (TIS)
- 6.6.1. Global multiplex biomarker imaging market toponome imaging system (TIS), 2024 - 2032 (USD Million)
- 6.1. Global multiplex biomarker imaging market: imaging techniques overview
- Chapter 7. Global Multiplex Biomarker Imaging Market - End-User Segment Analysis
- 7.1. Global multiplex biomarker imaging market: End User overview
- 7.1.1. Global multiplex biomarker imaging market revenue share, by end user, 2018 and 2032
- 7.2. Research Institutes Government & Private
- 7.2.1. Global multiplex biomarker imaging market for research institutes government & private, 2024 - 2032 (USD Million)
- 7.3. Clinical Labs
- 7.3.1. Global multiplex biomarker imaging market for clinical labs , 2024 - 2032 (USD Million)
- 7.4. Pharmaceutical & Biotechnology
- 7.4.1. Global multiplex biomarker imaging market for pharmaceutical & biotechnology, 2024 - 2032 (USD Million)
- 7.1. Global multiplex biomarker imaging market: End User overview
- Chapter 8. Global Multiplex Biomarker Imaging Market - Regional Segment Analysis
- 8.1. Global multiplex biomarker imaging market: regional overview
- 8.1.1. Global multiplex biomarker imaging market revenue share, by region, 2018 and 2032
- 8.1.2. North America
- 8.1.2.1. North America multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.1.2.2. North America multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.1.2.3. North America multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.1.3. The U.S.
- 8.1.3.1. The U.S. multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.1.3.2. The U.S. multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.1.3.3. The U.S. multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.1.4. Canada
- 8.1.4.1. Canada multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.1.4.2. Canada multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.1.4.3. Canada multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.2. Europe
- 8.2.1. Europe multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.2.2. Europe multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.2.3. Europe multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.2.4. U.K.
- 8.2.4.1. U.K. multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.2.4.2. U.K. multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.2.4.3. U.K. multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.2.5. Germany
- 8.2.5.1. Germany multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.2.5.2. Germany multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.2.5.3. Germany multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.2.6. France
- 8.2.6.1. France multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.2.6.2. France multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.2.6.3. France multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.2.7. Rest of Europe
- 8.2.7.1. Rest of Europe multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.2.7.2. Rest of Europe multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.2.7.3. Rest of Europe multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.3. Asia Pacific
- 8.3.1. Asia Pacific multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.3.2. Asia Pacific multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.3.3. Asia Pacific multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.3.4. China
- 8.3.4.1. China multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.3.4.2. China multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.3.4.3. China multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.3.5. Japan
- 8.3.5.1. Japan multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.3.5.2. Japan multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.3.5.3. Japan multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.3.6. India
- 8.3.6.1. India multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.3.6.2. India multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.3.6.3. India multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.3.7. Rest of Asia Pacific
- 8.3.7.1. Rest of Asia Pacific multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.3.7.2. Rest of Asia Pacific multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.3.7.3. Rest of Asia Pacific multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.4. Latin America
- 8.4.1. Latin America multiplex biomarker imaging market revenue, by application, 2024 - 2032(USD Million)
- 8.4.2. Latin America multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.4.3. Latin America multiplex biomarker imaging market revenue, by end user, 2024 - 2032(USD Million)
- 8.4.4. Brazil
- 8.4.4.1. Brazil multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.4.4.2. Brazil multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.4.4.3. Brazil multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.4.5. Rest of Latin America
- 8.4.5.1. Rest of Latin America multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.4.5.2. Rest of Latin America multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.4.5.3. Rest of Latin America multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.5. The Middle East and Africa
- 8.5.1. The Middle East and Africa multiplex biomarker imaging market revenue, by application, 2024 - 2032 (USD Million)
- 8.5.2. The Middle East and Africa multiplex biomarker imaging market revenue, by imaging techniques, 2024 - 2032 (USD Million)
- 8.5.3. The Middle East and Africa multiplex biomarker imaging market revenue, by end user, 2024 - 2032 (USD Million)
- 8.1. Global multiplex biomarker imaging market: regional overview
- Chapter 9. Company Profile
- 9.1. Thermo Fisher Scientific
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. PerkinElmer Inc.
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. Bio-Rad Laboratories, Inc.
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. Abcam Plc.,
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. US Biomax Inc.
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.6. Merck KGaA
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product portfolio
- 9.6.4. Business strategy
- 9.6.5. Recent developments
- 9.7. ToposNomos Ltd.
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product portfolio
- 9.7.4. Business strategy
- 9.7.5. Recent developments
- 9.8. MicroConstants, Inc.
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product portfolio
- 9.8.4. Business strategy
- 9.8.5. Recent developments
- 9.9. Aushon BioSystems Ltd.
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Product portfolio
- 9.9.4. Business strategy
- 9.9.5. Recent developments
- 9.10. Ventana Medical Systems, Inc.
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Product portfolio
- 9.10.4. Business strategy
- 9.10.5. Recent developments
- 9.11. Leica Biosystems Nussloch GmbH
- 9.11.1. Overview
- 9.11.2. Financials
- 9.11.3. Product portfolio
- 9.11.4. Business strategy
- 9.11.5. Recent developments
- 9.12. Illumina Inc.
- 9.12.1. Overview
- 9.12.2. Financials
- 9.12.3. Product portfolio
- 9.12.4. Business strategy
- 9.12.5. Recent developments
- 9.1. Thermo Fisher Scientific
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global multiplex biomarker imaging market revenue, 2024 – 2032 (USD Million)
4. Porter’s five forces analysis
5. Global multiplex biomarker imaging market attractiveness analysis, by application
6. Global multiplex biomarker imaging market attractiveness analysis, by imaging techniques
7. Global multiplex biomarker imaging: market attractiveness analysis, by end user
8. Global multiplex biomarker imaging: market attractiveness analysis, by regional segment
9. Company market share analysis, 2024
10. Global multiplex biomarker imaging market revenue share by application, 2024 and 2032
11. Global multiplex biomarker imaging market for drug safety, 2024 – 2032 (USD Million)
12. Global multiplex biomarker imaging market for oncology studies, 2024 – 2032 (USD Million)
13. Global multiplex biomarker imaging market for genetic characterization studies, 2024 – 2032 (USD Million)
14. Global multiplex biomarker imaging market revenue share by imaging techniques, 2024 and 2032
15. Global multiplex biomarker imaging market for immuno fluorescence (IF) assay, 2024 – 2032 (USD Million)
16. Global multiplex biomarker imaging market for tissue microarray (TMA) assay , 2024 – 2032 (USD Million)
17. Global multiplex biomarker imaging market for immunohistochemistry (IHC) assay, 2024 – 2032 (USD Million)
18. Global multiplex biomarker imaging market for fluorescent in the situ hybridization (FISH) assay, 2024 – 2032 (USD Million)
19. Global multiplex biomarker imaging market for toponome imaging system (TIS), 2024 – 2032 (USD Million)
20. Global multiplex biomarker imaging market revenue share by end user, 2024 and 2032
21. Global multiplex biomarker imaging market for research institutes government & private , 2024 – 2032 (USD Million)
22. Global multiplex biomarker imaging market for clinical labs , 2024 – 2032 (USD Million)
23. Global multiplex biomarker imaging market for pharmaceutical & biotechnology, 2024 – 2032 (USD Million)
24. North America multiplex biomarker imaging market, 2024 - 2032 (USD Million)
25. Europe multiplex biomarker imaging market, 2024 - 2032 (USD Million)
26. Asia Pacific multiplex biomarker imaging market, 2024 - 2032 (USD Million)
27. Latin America multiplex biomarker imaging market, 2024 - 2032 (USD Million)
28. The Middle East and Africa multiplex biomarker imaging market, 2024 - 2032 (USD Million)
Table Of Tables
List of Tables
1. Multiplex biomarker imaging market: market snapshot
2. Drivers of global multiplex biomarker imaging market: impact analysis
3. Restraints of global multiplex biomarker imaging market: impact analysis
4. North America multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
5. North America multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
6. North America multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
7. The U.S. multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
8. The U.S. multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
9. The U.S. multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
10. Canada multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
11. Canada multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
12. Canada multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
13. Europe multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
14. Europe multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
15. Europe multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
16. U.K. multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
17. U.K. multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
18. U.K. multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
19. Germany multiplex biomarker imaging market revenue, by application, 2024 – 2032
20. Germany multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
21. Germany multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
22. France multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
23. France multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
24. France multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
25. Rest of Europe multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
26. Rest of Europe multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
27. Rest of Europe multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
28. Asia Pacific multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
29. Asia Pacific multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
30. Asia Pacific multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
31. China multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
32. China multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
33. China multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
34. Japan multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
35. Japan multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
36. Japan multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
37. India multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
38. India multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
39. India multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
40. Rest of Asia Pacific multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
41. Rest of Asia Pacific multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
42. Rest of Asia Pacific multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
43. Latin America multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
44. Latin America multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
45. Latin America multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
46. Brazil multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
47. Brazil multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
48. Brazil multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
49. Rest of Latin America multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
50. Rest of Latin America multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
51. Rest of Latin America multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
52. The Middle East & Africa multiplex biomarker imaging market revenue, by application, 2024 – 2032 (USD Million)
53. The Middle East & Africa multiplex biomarker imaging market revenue, by imaging techniques, 2024 – 2032 (USD Million)
54. The Middle East & Africa multiplex biomarker imaging market revenue, by end user, 2024 – 2032 (USD Million)
Methodology
FrequentlyAsked Questions
Multiplex biomarker imaging is at the cutting edge of medical diagnostics and research, transforming the process of analyzing tissue samples.
According to a study, the global multiplex biomarker imaging market size was worth around USD 469.57 million in 2023 and is expected to reach USD 1,309.50 million by 2032.
The global multiplex biomarker imaging market is expected to grow at a CAGR of 12.07% during the forecast period.
North America is expected to dominate the multiplex biomarker imaging market over the forecast period.
Leading players in the global multiplex biomarker imaging market include Thermo Fisher Scientific, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abcam Plc., US Biomax Inc., Merck KGaA, ToposNomos Ltd., MicroConstants, Inc., Aushon BioSystems Ltd., Ventana Medical Systems, Inc., Leica Biosystems Nussloch GmbH, Illumina Inc., among others.
The multiplex biomarker imaging market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.
HappyClients
